Evaluation fees

Review fees

Fees charged are for REB review and for the support provided by the Research Ethics Office (REO), not the approval. Please note that projects reviewed by the REB will be billed even if the project will not occur regardless of the cause of non-fulfillment.  

Review type



  • Initial Full Board Review


  • Initial review of the protocol
  • Ongoing review


  • Annual renewal done by Full Board or Delegated review
  • Amendments requiring a Full Board review (incident report, TI and SAE) or changes requested by the industry (protocol amendment, consent form)




  • Major amendement
  • Increasing the scope of the study


  • Addition of one or two objectives, therefore a new study


  • This review fee applies to research projects funded by a third party (individual, private industry or when is contractually responsible, in totality or partially, for receiving data/publication rights and/or access to records for clinical trials that will be submitted to the REB for review.

Example :

  • Pharmaceutical products and medical device
    • Research team submitting a protocol finance by industry
    • Research protocol financed by a Government agency which is not peer reviewed

Form to generate the invoice 

Please complete the billing form (for internal use and available in French only at this time) and submit it to the REB Office. This step is part of the submission process (initial or renewal).